Generation of a heterozygous C-peptide-mCherry reporter human iPSC line (HMGUi001-A-8).
Stem Cell Res. 50:102126 (2021)
The peptide hormone insulin produced by pancreatic β-cells undergoes post-transcriptional processing before secretion. In particular, C-peptide is cleaved from pro-insulin to generate mature insulin. Here, we introduce a C-peptide-mCherry human iPSC line (HMGUi001-A-8). The line was generated by CRISPR/Cas9 mediated heterozygous insertion of the mCherry sequence into exon 3 of the insulin locus. We demonstrate that the line is pluripotent and efficiently differentiates towards pancreatic β-like cells, which localize a red fluorescent C-peptide-mCherry fusion protein in insulin containing granules. Hence, the HMGUi001-A-8 line is a valuable resource to purify derived β-like cells and follow insulin-containing granules in real time.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
2020
HGF-reported in Year
2020
ISSN (print) / ISBN
1873-5061
e-ISSN
1876-7753
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 50,
Issue: ,
Pages: ,
Article Number: 102126
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Radarweg 29, 1043 Nx Amsterdam, Netherlands
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
30204 - Cell Programming and Repair
Research field(s)
Helmholtz Diabetes Center
Enabling and Novel Technologies
Stem Cell and Neuroscience
PSP Element(s)
G-502300-001
G-501900-231
G-503000-001
G-500800-001
Grants
HumEN consortium - European Union's Seventh Framework Programme for Research, Technological Development and Demonstration
Deutsches Zentrum fur Diabetesforschung (DZD)
Helmholtz-Gemeinschaft (Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease)
Copyright
Erfassungsdatum
2021-01-03